Pfizer claims that its COVID-19 vaccine can be used safely and effectively for children between the ages of 5 and 11.
The main question on many parents’ heads at the moment is when can my child be able to get one?
A large number of children have been found positive for COVID-19. About 460 people have died. Children have been particularly affected in the Delta variant wave. As of September. 2 the number of children affected was 15.1 percent of cases reported throughout the course of the epidemic; in the last week of September. 2, they accounted for 26.8 percent of all cases according to the American Academy of Pediatrics. This represents an increase of 250% in cases of children since the period of July 22-29.
According to an article in the Atlantic Some parents have played with their kid’s birth dates so that they receive shots just short of the 12-year mark for their shots. (The FDA does not recommend this.) Some have sought out doctors who will vaccinate young children using off-label methods. (Also not suggested.) In the event that the dose is recommended for children between the ages of 5 and 11, these types of workarounds are ineffective.
We know today about the timeframe for having children under the age of 12 vaccinated.
Are we even close to the COVID-19 vaccine for children?
The news came out on Monday. Pfizer has announced that it is going to request an emergency-use permit for its COVID-19 vaccine, which is aimed at children between the ages of 5 and 11. The doctor. Bill Gruber, a Pfizer vice president in charge of the senior division, said to The Associated Press that the drugmaker employed a lower dosage that contained the exact vaccine approximately one-third of the dose in the older version for 12 and over when testing it on younger children. The results: Same antibodies were detected in the subjects as for older teens who were given the standard dose.
The FDA’s chief vaccine officer stated earlier this month that he’s “very positive” in the event that vaccinations are approved and distributed to children aged 5-11 before the end of the year. in the same conversation, he mentioned that after the FDA receives the data received from Pfizer, “we’re going to conduct a thorough investigation on the information as fast as possible” and make an answer “hopefully within the next few weeks, not a matter of months.”
There’s no timetable official to determine how long this will take. Pfizer filed this vaccine in the event of emergency authorizations for adults in November. 20th, 2020 and was granted the authorization three weeks after that on December. 11. The full FDA authorization was issued in August. 23rd, 2021.
The announcement made on Monday stated that Pfizer intends to apply for the same emergency-use authorization to the children version by the end of the month.
What is the difference between Moderna and Johnson & Johnson?
The Moderna clinical trials for children six to eleven are currently in progress. In July The New York Times reported that the Pfizer trials were running faster than the competition’s mRNA vaccine.
It is important to note that the Johnson & Johnson vaccine has an emergency-use permit for individuals aged 18 and over. In the month of April, the company is currently in the 3rd phase of clinical trials in order to examine its vaccine in adolescents aged 12-17 years old.
What is the earliest date that children under five will get the chance to receive vaccinations?
Pfizer announced in July that it was expecting to report results from the trials of children aged 5-11 by September, for children aged 2-5 shortly after as well as toddlers and infants between 6 months and 2 years old by October or November. It’s been confirmed with the first results, with no indication of delay in the trials of any smaller age categories. Moderna announced that it will conduct trials for babies as young as six months old.
Therefore, the answer is: The trials are still in progress. We’ll find out more over the next few months or so.